In one paragraphArticle in Journal of bacteriology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
6 authors.
Gregory A HarrisonDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-6050-1312 Pola KuhnDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Shailab ShresthaDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0009-0009-6830-1698 Paula Caballero BlancoDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Larissa HaveyDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0009-0009-4078-1773 Aimee ShenDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-9786-5742 Funding
Tufts IRACDAK12GM133314 · NIGMS · TUFTS UNIVERSITY BOSTON · PI CLAIRE L MOORE, Jamie Lynn Maguire · 2019 to 2026
$8.4MSpore Assembly in Clostridium DifficileR01AI122232 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SHEN, AIMEE · 2016 to 2025
$4.2MDefining the unique divisome of Clostridioides difficileF32AI191529 · NIAID · TUFTS UNIVERSITY BOSTON · PI Gregory Alexander Harrison · 2025 to 2026
$155kNational Institute of Allergy and Infectious Diseases F32AI191529National Institute of Allergy and Infectious Diseases R01AI122232NIAID NIH HHS F32 AI191529NIAID NIH HHS R01 AI122232NIGMS NIH HHS K12 GM133314NIGMS NIH HHS K12GM133314
6 · The paper itselfAbstract
Cell division is the ancient pathway by which bacteria synthesize a septum of peptidoglycan, dividing the cell into two. Although all walled bacteria were previously thought to use FtsW-FtsI orthologs to synthesize septal peptidoglycan during division, we recently discovered that the major pathogen
Indexed as
Bacterial ProteinsCell DivisionClostridioides difficileCytoskeletal ProteinsPenicillin-Binding ProteinsPeptidoglycanBacterial ProteinsCytoskeletal ProteinsFtsZ protein, BacteriaPenicillin-Binding ProteinsPeptidoglycancell divisionClostridioides difficileCRISPR-interferencedivisomeFtsZpenicillin-binding proteinSepFZapA
Identifiers
PMID42658112
PMCPMC13584725
What OpenQuestion holds
Textmetadata
Read underepoch 390